Telix Pharmaceuticals Ltd has released a press release.
Telix Successfully Prices A$650M Convertible Bonds
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Telix Announces A$600 Million Convertible Bonds Offering
- Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
- CMS proposes payment improvement for radiopharma diagnostics
- Telix Elects to Withdraw from Proposed U.S. Listing
- Trading Halt
Later from Telix Pharmaceuticals
- Convertible Bond Cleansing Notice
- Telix Completes A$650 Million of Convertible Bonds
- Telix 1H 2024 Appendix 4D and Interim Report
- Telix 1H 2024 Results Presentation
- Telix 1H 2024 Results Release
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals